Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Vang

Showing results (61-70 of 155) with videos related to

Pageof 16
Sort By:
Gynecologic Oncology|November 13, 2016
A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinomaCharlotte Gerd Hannibal, Russell Vang, Jette Junge, et al.
Gynecologic Oncology Reports|March 28, 2020
Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case reportOmar Najjar, Aaron Varghese, Maryam Shahi, et al.
The American Journal of Surgical Pathology|March 2, 2017
Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 CasesRussell Vang, Charlotte G Hannibal, Jette Junge, et al.
The American Journal of Surgical Pathology|September 7, 2022
Molecular Analysis of HPV-independent Primary Endometrial Squamous Cell Carcinoma Reveals TP53 and CDKN2A Comutations : A Clinicopathologic Analysis With Re-evaluation of Diagnostic CriteriaMark R Hopkins, Doreen N Palsgrove, Brigitte M Ronnett, et al.
Gynecologic Oncology|February 29, 2012
A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: a population-based study of 4317 women diagnosed in Denmark 1978-2006Charlotte Gerd Hannibal, Russell Vang, Jette Junge, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 14, 2015
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian StudyRussell Vang, Douglas A Levine, Robert A Soslow, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 22, 2005
Pseudoinfiltrative tubal metaplasia of the endocervix: a potential form of in utero diethylstilbestrol exposure-related adenosis simulating minimal deviation adenocarcinomaRussell Vang, Tuyethoa N Vinh, R Tucker Burks, et al.
Annals of Diagnostic Pathology|February 5, 2005
Elevated expression of p21 (WAF1/Cip1) in hormonally active pituitary adenomasAntonio G Neto, Ian E McCutcheon, Russell Vang, et al.
Human Pathology|October 18, 2005
Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcomeChih-Yi Hsu, Robert J Kurman, Russell Vang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotypingNatalie Banet, Cheryl DeScipio, Kathleen M Murphy, et al.
Pageof 16

Showing results (61-70 of 155) with videos related to

Sort By:
Pageof 16
Gynecologic Oncology|November 13, 2016
A nationwide study of ovarian serous borderline tumors in Denmark 1978-2002. Risk of recurrence, and development of ovarian serous carcinomaCharlotte Gerd Hannibal, Russell Vang, Jette Junge, et al.
Gynecologic Oncology Reports|March 28, 2020
Aromatase inhibitor therapy in recurrent, estrogen-receptor positive uterine serous carcinoma: A case reportOmar Najjar, Aaron Varghese, Maryam Shahi, et al.
The American Journal of Surgical Pathology|March 2, 2017
Long-term Behavior of Serous Borderline Tumors Subdivided Into Atypical Proliferative Tumors and Noninvasive Low-grade Carcinomas: A Population-based Clinicopathologic Study of 942 CasesRussell Vang, Charlotte G Hannibal, Jette Junge, et al.
The American Journal of Surgical Pathology|September 7, 2022
Molecular Analysis of HPV-independent Primary Endometrial Squamous Cell Carcinoma Reveals TP53 and CDKN2A Comutations : A Clinicopathologic Analysis With Re-evaluation of Diagnostic CriteriaMark R Hopkins, Doreen N Palsgrove, Brigitte M Ronnett, et al.
Gynecologic Oncology|February 29, 2012
A binary histologic grading system for ovarian serous carcinoma is an independent prognostic factor: a population-based study of 4317 women diagnosed in Denmark 1978-2006Charlotte Gerd Hannibal, Russell Vang, Jette Junge, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|July 14, 2015
Molecular Alterations of TP53 are a Defining Feature of Ovarian High-Grade Serous Carcinoma: A Rereview of Cases Lacking TP53 Mutations in The Cancer Genome Atlas Ovarian StudyRussell Vang, Douglas A Levine, Robert A Soslow, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|September 22, 2005
Pseudoinfiltrative tubal metaplasia of the endocervix: a potential form of in utero diethylstilbestrol exposure-related adenosis simulating minimal deviation adenocarcinomaRussell Vang, Tuyethoa N Vinh, R Tucker Burks, et al.
Annals of Diagnostic Pathology|February 5, 2005
Elevated expression of p21 (WAF1/Cip1) in hormonally active pituitary adenomasAntonio G Neto, Ian E McCutcheon, Russell Vang, et al.
Human Pathology|October 18, 2005
Nuclear size distinguishes low- from high-grade ovarian serous carcinoma and predicts outcomeChih-Yi Hsu, Robert J Kurman, Russell Vang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|July 27, 2013
Characteristics of hydatidiform moles: analysis of a prospective series with p57 immunohistochemistry and molecular genotypingNatalie Banet, Cheryl DeScipio, Kathleen M Murphy, et al.
Pageof 16